NARCOLEPSY TYPE 1 (NT1)

Clinical trials for NARCOLEPSY TYPE 1 (NT1) explained in plain language.

Never miss a new study

Get alerted when new NARCOLEPSY TYPE 1 (NT1) trials appear

Sign up with your email to follow new studies for NARCOLEPSY TYPE 1 (NT1), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial aims to tame sudden sleep attacks

Disease control Recruiting now

This study is testing if an investigational drug called TAK-861 can effectively control the symptoms of narcolepsy type 1, a sleep disorder that causes severe daytime sleepiness and sudden muscle weakness (cataplexy). About 88 participants worldwide will take the drug for several…

Matched conditions: NARCOLEPSY TYPE 1 (NT1)

Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

NARCOLEPSY TYPE 1 (NT1)

Get alerted when new NARCOLEPSY TYPE 1 (NT1) trials appear

New drug trial aims to tame sudden sleep attacks